Showing results (41-50 of 390) with videos related to
Sort By:
Pageof 39
Biochemical and Biophysical Research Communications|August 14, 1986
Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factorD O Morgan, R A RothDrug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1976
Role of blood flow in carbon monoxide- and hypoxic hypoxia-induced alterations in hexobarbital metabolism in ratsR A Roth, R J RubinToxicology and Applied Pharmacology|November 1, 1988
Dieldrin activates rat neutrophils in vitroJ A Hewett, R A RothBritish Journal of Pharmacology|October 1, 1993
Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cellsC M Hoorn, R A RothToxicology and Applied Pharmacology|July 1, 1993
Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrroleA E Schultze, R A RothThe Journal of Biological Chemistry|January 27, 1995
Characterization of the endogenous insulin receptor-related receptor in neuroblastomasK S Kovacina, R A RothBritish Journal of Pharmacology|June 1, 1984
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazoneK S Hilliker, R A RothClinical Pharmacokinetics|September 1, 1979
Role of the lung in total body clearance of circulating drugsR A Roth, D A WiersmaToxicology and Applied Pharmacology|April 1, 1987
5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrroleP E Ganey, R A RothJournal of Toxicology and Environmental Health. Part B, Critical Reviews|October 20, 1998
Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic systemA E Schultze, R A RothPageof 39